Rubicon Research Approves Final Dividend for FY2025-26, Confirms AGM Details and Merger of Wholly Owned Subsidiary
Rubicon Research Limited announced key decisions made by its Board of Directors regarding future dividends and operational updates following a meeting held on July 20, 2026. The company set the date for its forthcoming Annual General Meeting (AGM) and provided details concerning the merger of its wholly owned subsidiary, Kia Health Tech Private Limited.The Board approved several resolutions related to the upcoming AGM and dividend payment for the financial year ended March 31, 2026. Key dates were fixed for shareholders involved in the determination of eligibility for the final dividend on equity shares.
| Symbol | Type of Security | Record Date | Purpose |
|---|---|---|---|
| BSE: 544578 NSE: RUBICON | Fully paid-up equity shares of face value Re. 1/- each (ISIN: INE506V01022) | Friday, August 7, 2026 | Determination of members eligible for payment of final dividend for the financial year 2025-26. |
The AGM is scheduled to be held on Wednesday, August 26, 2026, through Video Conferencing or other Audio Visual Means. The Board had previously recommended a final dividend of ₹1.50 per equity share (on fully paid-up shares) for the financial year ended March 31, 2026. If approved by members and subject to tax deduction at source, the dividend is slated for payment within 30 days of approval.
Update on Merger with Kia Health Tech Private Limited
The Board of Directors also addressed the Scheme of Merger involving Rubicon Research Limited and its wholly owned subsidiary, Kia Health Tech Private Limited. The merger follows an in-principle approval granted on February 3, 2026.Under the Scheme, which has an Appointed Date of April 1, 2026, both boards have approved the amalgamation process. Since Kia Health Tech Private Limited is a wholly owned subsidiary of Rubicon Research Limited, no shares of the company will be issued and no consideration will be payable pursuant to the merger. Consequently, there will be no change in the shareholding pattern or voting rights of Rubicon Research Limited following the merger.
The Board meeting commenced at 4:30 PM (IST) and concluded at 5:00 PM (IST).
RUBICON Stock Price Movement
Rubicon Research Limited’s stock rallied sharply today during the post-market session, settling at ₹1511.80 after shareholders realized a 5.59% gain. The strong closing performance was backed by high volume—350,627 shares traded—as the company traded deep within its yearly trading range.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.